financetom
Business
financetom
/
Business
/
Teradata Q3 Results a Step Forward but More Progress Needed for 2026 Recurring Revenue Growth, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Teradata Q3 Results a Step Forward but More Progress Needed for 2026 Recurring Revenue Growth, Morgan Stanley Says
Nov 5, 2025 8:49 AM

11:37 AM EST, 11/05/2025 (MT Newswires) -- Teradata's ( TDC ) Q3 results are a step forward for the company, but it still needs to stabilize net expansion rates, set the "proper" expectations on Cloud annual recurring revenue growth, and drive sales of new solutions to ensure recurring revenue grows in 2026, Morgan Stanley analysts said in a Wednesday note.

Teradata ( TDC ) reported Q3 non-GAAP earnings of $0.72 per diluted share, ahead of $0.54 expected in a FactSet poll. Total revenue for the quarter was $416 million, compared with FactSet analyst expectations of $406.3 million.

Morgan Stanley raised the company's 2025 and 2026 EPS estimates to $2.39 and $2.49, respectively.

Analysts said the full impact of Teradata's ( TDC ) cost initiatives is yet to be seen, and therefore, operating expenses should fall further in 2026, setting up for a year of more notable operating margin expansion and stronger free cash flow growth.

Morgan Stanley increased the stock's price target to $30 from $28, and retained an overweight rating.

Teradata ( TDC ) shares were up 25% in recent Wednesday trading.

Price: 25.90, Change: +5.19, Percent Change: +25.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Houlihan Lokey Insider Sold Shares Worth $7,998,000, According to a Recent SEC Filing
Houlihan Lokey Insider Sold Shares Worth $7,998,000, According to a Recent SEC Filing
Aug 28, 2025
06:01 PM EDT, 08/28/2025 (MT Newswires) -- Paul Eric Siegert, Co-Chairman, on August 27, 2025, sold 40,000 shares in Houlihan Lokey ( HLI ) for $7,998,000. SEC Filing: https://www.sec.gov/Archives/edgar/data/1302215/000114266225000005/xslF345X05/wk-form4_1756418163.xml ...
Cameco flags 2025 production hit amid McArthur River mine transition delays
Cameco flags 2025 production hit amid McArthur River mine transition delays
Aug 28, 2025
Aug 28 (Reuters) - Canadian uranium supplier Cameco Corp ( CCJ ) said on Thursday the development delays in transitioning the McArthur River mine in Saskatchewan to new mining areas are expected to impact its 2025 production forecast. The company cited risks including development delays and the expected timing of ground freezing as the mine transitions into two new mining...
FTC chair alleges partisan filtering by Gmail; Google says spam filters not ideological
FTC chair alleges partisan filtering by Gmail; Google says spam filters not ideological
Aug 28, 2025
* Republicans have accused tech platforms of suppressing conservative views * Tech platforms deny claims * FTC chair's letter warns Google may face probe if it violates regulations (Adds Google comment, quote from letter warning about a probe, past lawsuit in paragraphs 2, 5-9) By Kanishka Singh WASHINGTON, Aug 28 (Reuters) - U.S. Federal Trade Commission Chairman Andrew Ferguson alleged...
Sionna Therapeutics Insider Sold Shares Worth $624,361, According to a Recent SEC Filing
Sionna Therapeutics Insider Sold Shares Worth $624,361, According to a Recent SEC Filing
Aug 28, 2025
05:45 PM EDT, 08/28/2025 (MT Newswires) -- Michael Cloonan, Director, President & CEO, on August 26, 2025, sold 25,000 shares in Sionna Therapeutics ( SION ) for $624,361. Following the Form 4 filing with the SEC, Cloonan has control over a total of 547,343 common shares of the company, with 547,343 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2036042/000203604225000051/xslF345X05/edgardoc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved